GSK recruiting trials & Exclusions / comparisons:
Post# of 154604
(Total Views: 895)
Posted On: 02/13/2025 1:00:32 AM
GSK recruiting trials & Exclusions / comparisons:
Antiviral Long Acting Drugs Landing in People Living With HIV.
study aimed at comparing hospital-based and home-based administration of CAB LA + RPV LA treatment for HIV-1-infected patients.
Exclusions:
*Women who are pregnant, breastfeeding or plan to become pregnant or breastfeed during the study
*History of liver cirrhosis with or without hepatitis viral co-infection.
*Ongoing or clinically relevant pancreatitis
Dr. Sacha has breastfeeding successes & he mentioned it in his Oct. 2024 video.
& of course now our significant liver news.
https://clinicaltrials.gov/study/NCT06468995?...amp;rank=3
Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme.
Cytodyn on Dec.17th, 2024:
"The company has committed to repeating the study based on unpublished observations by Dr. Pestell’s lab and will now employ a treatment sequence involving temozolomide and leronlimab.
https://clinicaltrials.gov/study/NCT02331498?...p;rank=199
First Time in Human Study of Long Acting VH4524184 Formulations.
Exclusions:
*Lymphoma, leukemia, or any malignancy within the past 5 years except for basal cell or squamous epithelial carcinomas of the skin that have been resected with no evidence of metastatic disease for 3 years.
*Breast cancer within the past 10 years.
*Current or chronic history of liver disease or known hepatic or biliary abnormalities.
https://clinicaltrials.gov/study/NCT06310551?...mp;rank=62
Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
https://clinicaltrials.gov/study/NCT06079190?...mp;rank=87
A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis
https://clinicaltrials.gov/study/NCT06317285?...mp;rank=60
Shows Leronlimab, LL-PLS, & AAV Vector delivery would be an outstanding addition to GSK, Pfizer & a GSK/Pfizer collab on our pipeline.
Not to leave out our recent:
Pulmonary Fibrosis/--heart, stroke & "other organs".
GF/ViiV liscenses Hiv & royalties.
Madgril liscenses MASH & royalties.
Gates Ventures liscenses Alzheimer’s & royalties.
Max Lataillade = GSK/Pfizer 1st pick @ a basket of indications. (??)
He proceed to liscence & royalties to others.
Cytodyn gets billions in the bank.
That meets $$ requirements for NASDAQ.
Later, dividends are based on your Cytodyn shares.
Antiviral Long Acting Drugs Landing in People Living With HIV.
study aimed at comparing hospital-based and home-based administration of CAB LA + RPV LA treatment for HIV-1-infected patients.
Exclusions:
*Women who are pregnant, breastfeeding or plan to become pregnant or breastfeed during the study
*History of liver cirrhosis with or without hepatitis viral co-infection.
*Ongoing or clinically relevant pancreatitis
Dr. Sacha has breastfeeding successes & he mentioned it in his Oct. 2024 video.
& of course now our significant liver news.
https://clinicaltrials.gov/study/NCT06468995?...amp;rank=3
Phase I/II Study of Pazopanib+ Temozolomide in Patients With Newly Diagnosed Glioblastoma Multiforme.
Cytodyn on Dec.17th, 2024:
"The company has committed to repeating the study based on unpublished observations by Dr. Pestell’s lab and will now employ a treatment sequence involving temozolomide and leronlimab.
https://clinicaltrials.gov/study/NCT02331498?...p;rank=199
First Time in Human Study of Long Acting VH4524184 Formulations.
Exclusions:
*Lymphoma, leukemia, or any malignancy within the past 5 years except for basal cell or squamous epithelial carcinomas of the skin that have been resected with no evidence of metastatic disease for 3 years.
*Breast cancer within the past 10 years.
*Current or chronic history of liver disease or known hepatic or biliary abnormalities.
https://clinicaltrials.gov/study/NCT06310551?...mp;rank=62
Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease
https://clinicaltrials.gov/study/NCT06079190?...mp;rank=87
A Study to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis
https://clinicaltrials.gov/study/NCT06317285?...mp;rank=60
Shows Leronlimab, LL-PLS, & AAV Vector delivery would be an outstanding addition to GSK, Pfizer & a GSK/Pfizer collab on our pipeline.
Not to leave out our recent:
Pulmonary Fibrosis/--heart, stroke & "other organs".
GF/ViiV liscenses Hiv & royalties.
Madgril liscenses MASH & royalties.
Gates Ventures liscenses Alzheimer’s & royalties.
Max Lataillade = GSK/Pfizer 1st pick @ a basket of indications. (??)
He proceed to liscence & royalties to others.
Cytodyn gets billions in the bank.
That meets $$ requirements for NASDAQ.
Later, dividends are based on your Cytodyn shares.
(2)
(0)